A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body
NCT05515588 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2024-09-20
Summary
The trial is intended to investigate the basic pharmacokinetics, excretion pathways and metabolism of BI 690517 and its metabolites.
Conditions
- Healthy
Interventions
- DRUG
-
BI 690517 (C-14)
BI 690517 (C-14)
- DRUG
-
BI 690517
BI 690517
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-19
- Primary Completion
- 2022-11-17
- Completion
- 2022-11-17
Countries
- Netherlands
Study Locations
More Related Trials
-
A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body
NCT06166992 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
NCT05857878 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body
NCT03230487 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet
NCT03783000 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body
NCT04567316 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood
NCT03892616 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 3032950 Are Tolerated
NCT05518708 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How BI 1819479 is Taken up and Processed by the Body
NCT07065617 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Tolerability of BI 685509 in Healthy Subjects
NCT03116906 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated
NCT06429137 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers
NCT02093819 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.
NCT01343719 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects
NCT02175238 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations
NCT06631417 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body
NCT06572111 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
NCT04065295 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
NCT06631430 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food
NCT05520827 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers
NCT01594515 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood
NCT07250048 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 10773 in Healthy Male Subjects
NCT02172170 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects
NCT03302078 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food
NCT05337592 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood
NCT03210272 ·Status: COMPLETED ·Phase: PHASE1